Authors:
OVERTURF K
ALDHALIMY M
MANNING K
OU CN
FINEGOLD M
GROMPE M
Citation: K. Overturf et al., EX-VIVO HEPATIC GENE-THERAPY OF A MOUSE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Human gene therapy, 9(3), 1998, pp. 295-304
Authors:
GROMPE M
OVERTURF K
ALDHALIMY M
FINEGOLD M
Citation: M. Grompe et al., THERAPEUTIC TRIALS IN THE MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I - A PROGRESS REPORT, Journal of inherited metabolic disease, 21(5), 1998, pp. 518-531
Authors:
OVERTURF K
ALDHALIMY M
OU CN
FINEGOLD M
TANGUAY R
LIEBER A
KAY M
GROMPE M
Citation: K. Overturf et al., ADENOVIRUS-MEDIATED GENE-THERAPY IN A MOUSE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Human gene therapy, 8(5), 1997, pp. 513-522
Authors:
OVERTURF K
ALDHALIMY M
FINEGOLD M
GROMPE M
Citation: K. Overturf et al., SERIAL TRANSPLANTATION REVEALS STEM-CELL LIKE REGENERATIVE POTENTIAL IN PARENCHYMAL MOUSE HEPATOCYTE, The FASEB journal, 11(3), 1997, pp. 604-604
Authors:
OVERTURF K
ALDHALIMY M
OU CN
FINEGOLD M
GROMPE M
Citation: K. Overturf et al., SERIAL TRANSPLANTATION REVEALS THE STEM-CELL-LIKE REGENERATIVE POTENTIAL OF ADULT-MOUSE HEPATOCYTES, The American journal of pathology, 151(5), 1997, pp. 1273-1280
Authors:
MANNING K
ALDHALIMY M
FINEGOLD M
MONTAGUTELLI X
GROMPE M
Citation: K. Manning et al., INHIBITION OF HOMOGENTISIC ACID OXIDASE AS A TREATMENT FOR A MURINE MODEL OF HT1, American journal of human genetics, 61(4), 1997, pp. 287-287
Authors:
GROMPE M
ALDHALIMY M
OVERTURF K
FINEGOLD M
Citation: M. Grompe et al., LONG-TERM DIETARY AND PHARMACOLOGICAL THERAPY OF MURINE TYROSINEMIA TYPE-I, American journal of human genetics, 61(4), 1997, pp. 1462-1462
Authors:
OVERTURF K
ALDHALIMY M
FINEGOLD M
GROMPE M
Citation: K. Overturf et al., EX-VIVO HEPATIC GENE-THERAPY CORRECTS A MOUSE MODEL OF HT1 AND PROVIDES A MODEL FOR HEPATIC STEM-CELL DELINEATION, American journal of human genetics, 61(4), 1997, pp. 2094-2094
Authors:
OVERTURF K
ALDHALIMY M
TANGUAY R
BRANTLY M
OU CN
FINEGOLD M
GROMPE M
Citation: K. Overturf et al., HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I (VOL 12, PG 266, 1996), Nature genetics, 12(4), 1996, pp. 458-458
Authors:
OVERTURF K
ALDHALIMY M
TANGUAY R
BRANTLY M
OU CN
FINEGOLD M
GROMPE M
Citation: K. Overturf et al., HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Nature genetics, 12(3), 1996, pp. 266-273
Authors:
GROMPE M
OVERTURF K
ALDHALIMY M
FINEGOLD M
Citation: M. Grompe et al., SERIAL TRANSPLANTATION REVEALS STEM-CELL LIKE REGENERATIVE POTENTIAL IN PARENCHYMAL MOUSE HEPATOCYTES, Hepatology, 24(4), 1996, pp. 519-519
Authors:
OVERTURF K
ALDHALIMY M
GROMPE M
FINEGOLD M
Citation: K. Overturf et al., SUCCESSFUL TREATMENT OF HEREDITARY TYROSINEMIA TYPE-1 IN A MOUSE MODEL BY HEPATOCELLULAR TRANSPLANTATION AND RETROVIRAL GENE DELIVERY, Laboratory investigation, 74(1), 1996, pp. 24-24
Authors:
GROMPE M
LINDSTEDT S
ALDHALIMY M
KENNAWAY NG
PAPACONSTANTINOU J
TORRESRAMOS CA
OU CN
FINEGOLD M
Citation: M. Grompe et al., PHARMACOLOGICAL CORRECTION OF NEONATAL LETHAL HEPATIC-DYSFUNCTION IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Nature genetics, 10(4), 1995, pp. 453-460
Citation: M. Grompe et M. Aldhalimy, RAPID NONRADIOACTIVE ASSAY FOR THE DETECTION OF THE COMMON FRENCH-CANADIAN TYROSINEMIA TYPE-1 MUTATION, Human mutation, 5(1), 1995, pp. 105-105
Authors:
GROMPE M
ALDHALIMY M
OU CN
BURLINGAME T
KENNAWAY N
LINDSTEDT S
FINEGOLD M
Citation: M. Grompe et al., PHARMACOLOGICAL CORRECTION OF LETHAL NEONATAL HEPATIC-DYSFUNCTION IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Laboratory investigation, 72(1), 1995, pp. 3-3
Authors:
OVERTURF IK
ALDHALIMY M
FINEGOLD M
GROMPE M
Citation: Ik. Overturf et al., HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE, American journal of human genetics, 57(4), 1995, pp. 188-188
Authors:
GROMPE M
STLOUIS M
DEMERS SI
ALDHALIMY M
LECLERC B
TANGUAY RM
Citation: M. Grompe et al., SINGLE MUTATION OF THE FUMARYLACETOACETATE HYDROLASE GENE IN FRENCH-CANADIANS WITH HEREDITARY TYROSINEMIA TYPE-I, The New England journal of medicine, 331(6), 1994, pp. 353-357
Citation: M. Grompe et M. Aldhalimy, MUTATIONS OF THE FUMARYLACETOACETATE HYDROLASE GENE IN 4 PATIENTS WITH TYROSINEMIA, TYPE-I, Human mutation, 2(2), 1993, pp. 85-93
Authors:
GROMPE M
ALDHALIMY M
FINEGOLD M
OU CN
BURLINGAME T
KENNAWAY NG
SORIANO P
Citation: M. Grompe et al., LOSS OF FUMARYLACETOACETATE HYDROLASE IS RESPONSIBLE FOR THE NEONATALHEPATIC-DYSFUNCTION PHENOTYPE OF LETHAL ALBINO MICE, Genes & development, 7(12A), 1993, pp. 2298-2307
Authors:
GROMPE M
ALDHALIMY M
KENNAWAY N
FINEGOLD M
SORIANO P
Citation: M. Grompe et al., CREATION OF A MOUSE MODEL OF FUMARYLACETOACETATE HYDROLASE DEFICIENCY, American journal of human genetics, 53(3), 1993, pp. 98-98
Authors:
TANGUAY RM
STLOUIS M
DEMERS SI
LECLERC B
ALDHALIMY M
GROMPE M
Citation: Rm. Tanguay et al., IDENTIFICATION OF A PREDOMINANT MUTATION IN HEREDITARY TYROSINEMIA TYPE-I PATIENTS FROM QUEBEC, American journal of human genetics, 53(3), 1993, pp. 954-954